CTI BioPharma Corp. Debt to Equity Ratio 2010-2023 | CTIC
Current and historical debt to equity ratio values for CTI BioPharma Corp. (CTIC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CTI BioPharma Corp. debt/equity for the three months ending March 31, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-03-31 | $0.14B | $-0.03B | -5.43 |
| 2022-12-31 | $0.14B | $-0.02B | -8.16 |
| 2022-09-30 | $0.14B | $-0.02B | -8.33 |
| 2022-06-30 | $0.14B | $-0.01B | -26.51 |
| 2022-03-31 | $0.16B | $-0.03B | -5.71 |
| 2021-12-31 | $0.07B | $0.00B | 18.23 |
| 2021-09-30 | $0.06B | $0.04B | 1.60 |
| 2021-06-30 | $0.02B | $0.06B | 0.26 |
| 2021-03-31 | $0.02B | $0.03B | 0.61 |
| 2020-12-31 | $0.02B | $0.04B | 0.46 |
| 2020-09-30 | $0.02B | $0.05B | 0.35 |
| 2020-06-30 | $0.02B | $0.06B | 0.34 |
| 2020-03-31 | $0.07B | $0.02B | 2.93 |
| 2019-12-31 | $0.03B | $0.02B | 1.58 |
| 2019-09-30 | $0.03B | $0.03B | 1.24 |
| 2019-06-30 | $0.03B | $0.04B | 0.89 |
| 2019-03-31 | $0.03B | $0.05B | 0.70 |
| 2018-12-31 | $0.04B | $0.05B | 0.70 |
| 2018-09-30 | $0.04B | $0.05B | 0.75 |
| 2018-06-30 | $0.04B | $0.06B | 0.61 |
| 2018-03-31 | $0.04B | $0.08B | 0.50 |
| 2017-12-31 | $0.04B | $0.02B | 2.41 |
| 2017-09-30 | $0.04B | $0.03B | 1.31 |
| 2017-06-30 | $0.05B | $0.04B | 1.22 |
| 2017-03-31 | $0.06B | $-0.01B | -5.31 |
| 2016-12-31 | $0.06B | $0.01B | 7.23 |
| 2016-09-30 | $0.06B | $0.01B | 5.11 |
| 2016-06-30 | $0.06B | $0.04B | 1.66 |
| 2016-03-31 | $0.07B | $0.06B | 1.26 |
| 2015-12-31 | $0.10B | $0.05B | 2.04 |
| 2015-09-30 | $0.09B | $-0.03B | -3.29 |
| 2015-06-30 | $0.09B | $-0.02B | -5.73 |
| 2015-03-31 | $0.05B | $0.01B | 3.39 |
| 2014-12-31 | $0.05B | $0.04B | 1.31 |
| 2014-09-30 | $0.05B | $0.02B | 1.87 |
| 2014-06-30 | $0.04B | $0.02B | 2.79 |
| 2014-03-31 | $0.04B | $0.04B | 1.00 |
| 2013-12-31 | $0.04B | $0.06B | 0.67 |
| 2013-09-30 | $0.03B | $0.01B | 2.41 |
| 2013-06-30 | $0.04B | $0.01B | 2.76 |
| 2013-03-31 | $0.04B | $0.03B | 1.21 |
| 2012-12-31 | $0.03B | $0.05B | 0.59 |
| 2012-09-30 | $0.03B | $0.00B | 9.14 |
| 2012-06-30 | $0.04B | $-0.00B | -26.73 |
| 2012-03-31 | $0.02B | $0.03B | 0.72 |
| 2011-12-31 | $0.02B | $0.04B | 0.50 |
| 2011-09-30 | $0.03B | $0.03B | 1.17 |
| 2011-06-30 | $0.04B | $0.02B | 2.46 |
| 2011-03-31 | $0.04B | $0.02B | 2.42 |
| 2010-12-31 | $0.05B | $0.01B | 5.44 |
| 2010-09-30 | $0.04B | $0.01B | 5.02 |
| 2010-06-30 | $0.08B | $0.02B | 4.61 |
| 2010-03-31 | $0.09B | $-0.01B | -8.78 |
| 2009-12-31 | $0.09B | $-0.02B | -4.84 |
| 2009-09-30 | $0.10B | $-0.01B | -10.16 |
| 2009-06-30 | $0.10B | $-0.06B | -1.78 |
| 2009-03-31 | $0.16B | $-0.12B | -1.37 |
